2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M)
文献类型:期刊论文
作者 | Smaill, Jeff; Lu, Xiaoyun; Cheng, Huimin; Zhang, Zhang; Li, Yingjun; Tong, Linjiang; Qu, Rong; Han, Kun; Chan, Shingpan; Ding, Ke |
刊名 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
![]() |
出版日期 | 2015 |
卷号 | 25期号:19页码:4277-4281 |
ISSN号 | 0960-894X |
学科主题 | Pharmacology & Pharmacy ; Chemistry |
语种 | 英语 |
源URL | [http://ir.foo.ac.cn/handle/2SETSVCV/817] ![]() |
专题 | 中国科学院广州生物医药与健康研究院 |
推荐引用方式 GB/T 7714 | Smaill, Jeff,Lu, Xiaoyun,Cheng, Huimin,et al. 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M)[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,2015,25(19):4277-4281. |
APA | Smaill, Jeff.,Lu, Xiaoyun.,Cheng, Huimin.,Zhang, Zhang.,Li, Yingjun.,...&Xie, Hua.(2015).2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M).BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,25(19),4277-4281. |
MLA | Smaill, Jeff,et al."2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M)".BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 25.19(2015):4277-4281. |
入库方式: OAI收割
来源:广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。